Table 4. Antibiotic resistance of ZJ-T, △hfq-T and hfq+-T.
Antibiotics | Concentration | Size of inhibition zone (mm) | p-value | ||
---|---|---|---|---|---|
(μg/per disk) | ZJ-T | Δhfq-T | hfq+-T | (Δhfq-T vs ZJ-T) a | |
lincomycin | 2 | 0 | 0 | 0 | 1.00 |
vancomycin | 30 | 8.80±1.30 | 13.40±0.89 | 8.40±1.52 | 0.00 |
clindamycin | 2 | 0 | 0 | 0 | 1.00 |
streptomycin | 300 | 12.60±1.52 | 14.80±1.92 | 12.67±2.08 | 0.24 |
ampicillin | 10 | 0 | 0 | 0 | 1.00 |
oxacillin | 1 | 0 | 0 | 0 | 1.00 |
piperacillin | 100 | 0 | 0 | 0 | 1.00 |
kanamycin | 30 | 11.80±0.84 | 14.40±1.52 | 11.40±1.14 | 0.00 |
penicillin-G | 10 | 0 | 0 | 0 | 1.00 |
cefazolin | 30 | 13.50±3.54 | 14.50±3.54 | 14.50±3.54 | 0.796 |
tobramycin | 10 | 11.00±2.00 | 14.67±0.58 | 11.00±1.73 | 0.03 |
neomycin | 30 | 14.67±1.15 | 17.00±1.00 | 14.67±1.15 | 0.04 |
novobiocin | 30 | 19.00±3.46 | 21.00±3.61 | 18.33±2.31 | 0.34 |
erythromycin | 15 | 16.00±1.00 | 17.67±3.06 | 16.33±1.53 | 0.36 |
medemycin | 30 | 11.00±1.41 | 11.50±0.71 | 11.00±1.41 | 0.71 |
polymyxin B | 300 | 13.50±2.12 | 14.00±1.41 | 12.50±2.12 | 0.81 |
acetylspiramycin | 30 | 0 | 0 | 0 | 1.00 |
spectinomycin | 100 | 12.50±0.71 | 11.00±1.41 | 10.50±2.12 | 0.40 |
cefixime | 5 | 16.67±4.73 | 19.35±1.15 | 18.33±4.04 | 0.41 |
amoxicillin | 10 | 0 | 0 | 0 | 1.00 |
azithromycin | 15 | 17.00±1.00 | 19.67±2.52 | 18.00±1.00 | 0.11 |
clarithromycin | 15 | 13.00±2.00 | 13.00±2.83 | 11.50±3.54 | 1.00 |
teicoplanin | 30 | 8.50±0.71 | 10.00±0.00 | 8.50±0.71 | 0.08 |
fosfomycin | 200 | 17.00±1.73 | 22.67±0.58 | 15.00±1.00 | 0.00 |
gentamicin | 120 | 19.50±0.71 | 18.50±0.71 | 16.50±0.71 | 0.25 |
a There is no significant difference (p>0.05) between the wild type ZJ-T and the complemented strain hfq+-T.